Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Calpurbatug by Trellis Bioscience for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections: Likelihood of Approval
Calpurbatug is under clinical development by Trellis Bioscience and currently in Phase I for Methicillin-Resistant Staphylococcus aureus (MRSA) Infections. According...
Calpurbatug by Trellis Bioscience for Gram-Positive Bacterial Infections: Likelihood of Approval
Calpurbatug is under clinical development by Trellis Bioscience and currently in Phase I for Gram-Positive Bacterial Infections. According to GlobalData,...
Calpurbatug by Trellis Bioscience for Gram-Negative Bacterial Infections: Likelihood of Approval
Calpurbatug is under clinical development by Trellis Bioscience and currently in Phase I for Gram-Negative Bacterial Infections. According to GlobalData,...
Calpurbatug by Trellis Bioscience for Prosthetic Joint infections: Likelihood of Approval
Calpurbatug is under clinical development by Trellis Bioscience and currently in Phase I for Prosthetic Joint infections. According to GlobalData,...